From: Liver biopsy is still needed in liver transplantation recipients: a single center experience
Recipients (n = 89) | p | |||
---|---|---|---|---|
Non-biopsied | Biopsied | |||
n = 55 (61.8%) | n = 34 (38.2%) | |||
Age years | 46.96 ± 8.74 | 44.65 ± 8.46 | 0.222 | |
MELD | 8.82 ± 2.86 | 8.74 ± 4.71 | 0.258# | |
ALBI score | − 2.96 ± 0.50 | − 2.62 ± 0.60 | 0.014# | |
Follow-up months | 38.40 ± 20.42 | 51.53 ± 15.92 | 0.001# | |
Sex | ||||
Male | 53 (96.4%) | 30 (88.2%) | 83 (93.3%) | 0.197 |
Female | 2 (3.6%) | 4 (11.8%) | 6 (6.7%) | |
Indication of LT | ||||
HCV | 33 (60%) | 21 (61.8%) | 54 (60.7%) | 0.192 |
HCV + HCC | 18 (32.7%) | 10 (29.4%) | 28 (31.5%) | |
HBV | 4 (7.3%) | 0 | 4 (4.5%) | |
HCV + HBV + HCC | 0 | 1 (2.9%) | 1 (1.1%) | |
PSC | 0 | 1 (2.9%) | 1 (1.1%) | |
AIH | 0 | 1 (2.9%) | 1 (1.1%) |